Dose of doxorubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Tumor Cells, Cultured Heart Myocardium Eyelids

Organisms3

Mice, Nude Rats, Sprague-Dawley Mice, Inbred BALB C

Diseases26

Breast Neoplasms Leukemia P388 Sarcoma Neoplasms Heart Diseases Cardiomyopathies Osteosarcoma Lung Neoplasms Leukopenia Neutropenia Ovarian Neoplasms Bone Neoplasms Soft Tissue Neoplasms Lymphoma, Non-Hodgkin Nausea Neoplasm Metastasis Lymphoma, Large B-Cell, Diffuse Hodgkin Disease Vomiting Neoplasm Recurrence, Local Thrombocytopenia Liver Neoplasms Adenocarcinoma Multiple Myeloma Disease Models, Animal Carcinoma, Small Cell

Chemicals and Drugs48

Doxorubicin Antibiotics, Antineoplastic Vincristine Razoxane Cyclophosphamide Antineoplastic Agents Drug Carriers Liposomes P-Glycoprotein Prednisone Paclitaxel Etoposide Polyethylene Glycols Vinblastine Cisplatin Daunorubicin Ifosfamide Cardiotoxins Hydroxyethylrutoside Bleomycin Anthracyclines Methotrexate Mitoxantrone Fluorouracil Antineoplastic Agents, Phytogenic Verapamil Taxoids Prodrugs DNA Topoisomerases, Type II Epirubicin Procarbazine Naphthacenes Nanocapsules Aclarubicin Antibodies, Monoclonal Granulocyte Colony-Stimulating Factor Dacarbazine Cyclosporins Topoisomerase II Inhibitors Antibodies, Monoclonal, Murine-Derived Mechlorethamine Multidrug Resistance-Associated Proteins Dexamethasone Tumor Suppressor Protein p53 Mitomycin Amifostine Deoxycytidine Rhodamine 123

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Drug Carriers Treatment Outcome Infusions, Intravenous Combined Modality Therapy Drug Delivery Systems Drug Screening Assays, Antitumor Lethal Dose 50 Disease-Free Survival Survival Analysis Radiation Dosage Injections, Intravenous Administration, Oral Survival Rate Chemotherapy, Adjuvant Neoplasm Transplantation Area Under Curve Drug Evaluation Xenograft Model Antitumor Assays Remission Induction Nanocapsules Radiotherapy Dosage Radiometry Random Allocation Neoplasm Staging Inhibitory Concentration 50 Dose-Response Relationship, Radiation Dose Fractionation Transplantation, Heterologous Double-Blind Method Metabolic Clearance Rate Neoadjuvant Therapy Prospective Studies Disease Models, Animal Follow-Up Studies

Phenomena and Processes20

Drug Resistance, Neoplasm Drug Resistance, Multiple Drug Synergism Dose-Response Relationship, Drug Apoptosis Time Factors Drug Resistance Cell Survival Lethal Dose 50 Radiation Dosage Drug Interactions Area Under Curve Inhibitory Concentration 50 Dose-Response Relationship, Radiation Genes, MDR DNA Damage Half-Life Cell Proliferation Tissue Distribution Metabolic Clearance Rate

Technology, Industry, Agriculture4

Liposomes Polyethylene Glycols Nanocapsules Nanoparticles

Information Science1

Health Care11

Treatment Outcome Disease-Free Survival Survival Analysis Radiation Dosage Survival Rate Area Under Curve Random Allocation Dose-Response Relationship, Radiation Double-Blind Method Prospective Studies Follow-Up Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care

Doxorubicin Antibiotics, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Vincristine Razoxane Cyclophosphamide Antineoplastic Agents Drug Administration Schedule Drug Resistance, Neoplasm Drug Carriers Liposomes P-Glycoprotein Prednisone Breast Neoplasms Cell Line, Tumor Drug Resistance, Multiple Treatment Outcome Paclitaxel Etoposide Polyethylene Glycols Vinblastine Cisplatin Drug Synergism Daunorubicin Dose-Response Relationship, Drug Infusions, Intravenous Combined Modality Therapy Leukemia P388 Apoptosis Time Factors Ifosfamide Tumor Cells, Cultured Cardiotoxins Hydroxyethylrutoside Drug Resistance Sarcoma Drug Delivery Systems Cell Survival Bleomycin Anthracyclines Drug Screening Assays, Antitumor Lethal Dose 50 Methotrexate Disease-Free Survival Survival Analysis Mitoxantrone Fluorouracil Antineoplastic Agents, Phytogenic Heart Radiation Dosage Verapamil Injections, Intravenous Neoplasms Heart Diseases Cardiomyopathies Administration, Oral Taxoids Mice, Nude Osteosarcoma Prodrugs Drug Interactions Survival Rate Lung Neoplasms Leukopenia Neutropenia Chemotherapy, Adjuvant Neoplasm Transplantation DNA Topoisomerases, Type II Epirubicin Area Under Curve Drug Evaluation Procarbazine Xenograft Model Antitumor Assays Ovarian Neoplasms Naphthacenes Remission Induction Nanocapsules Radiotherapy Dosage Bone Neoplasms Aclarubicin Soft Tissue Neoplasms Antibodies, Monoclonal Radiometry Granulocyte Colony-Stimulating Factor Lymphoma, Non-Hodgkin Dacarbazine Cyclosporins Nausea Topoisomerase II Inhibitors Random Allocation Neoplasm Staging Inhibitory Concentration 50 Antibodies, Monoclonal, Murine-Derived Mechlorethamine Myocardium Dose-Response Relationship, Radiation Genes, MDR Multidrug Resistance-Associated Proteins Neoplasm Metastasis DNA Damage

No FAQ available that match "dose of doxorubicin"